|
226
|
1134
|
8g71A |
Spike/nb2 complex with 1 rbd up |
|
221
|
756
|
8pm0B |
Influenza a/h7n9 polymerase in replicase-like conformation in pre-initiation state with pol ii ps5 ctd peptide mimic bound in site 1a/2a |
|
206
|
716
|
8r3kA |
Influenza a/h7n9 polymerase in self-stalled pre-termination state, with pol ii ps5 ctd peptide mimic bound in site 1a/2a. |
|
154
|
493
|
8phiF |
Crystal structure of prefusion-stabilized rsv f variant ds-cav1 in complex with lonafarnib |
|
99
|
296
|
8rzcA |
Sars-cov-2 nsp16-nsp10 in complex with sam derivative inhibitor 11 |
|
200
|
756
|
8r3lB |
Influenza a/h7n9 polymerase in pre-initiation state, intermediate conformation (i) with pb2-c(i), endo(t), and pol ii ps5 ctd peptide mimic bound in site 1a/2a |
|
28
|
115
|
8rzeB |
Sars-cov-2 nsp16-nsp10 in complex with sam derivative inhibitor 10 |
|
209
|
716
|
8pm0A |
Influenza a/h7n9 polymerase in replicase-like conformation in pre-initiation state with pol ii ps5 ctd peptide mimic bound in site 1a/2a |
|
0
|
25
|
8pnqG |
Influenza a/h7n9 polymerase in elongation state with continuous pol ii ps5 ctd peptide mimic bound in site 1a/2a |
|
128
|
515
|
8pohA |
Influenza a/h7n9 polymerase symmetric dimer bound to the promoter (pa k289a/c489r) |
|
28
|
115
|
8rzdB |
Sars-cov-2 nsp16-nsp10 in complex with sam derivative inhibitor 9 |
|
187
|
716
|
8r3lA |
Influenza a/h7n9 polymerase in pre-initiation state, intermediate conformation (i) with pb2-c(i), endo(t), and pol ii ps5 ctd peptide mimic bound in site 1a/2a |
|
146
|
677
|
8r3lC |
Influenza a/h7n9 polymerase in pre-initiation state, intermediate conformation (i) with pb2-c(i), endo(t), and pol ii ps5 ctd peptide mimic bound in site 1a/2a |
|
210
|
716
|
8pnqA |
Influenza a/h7n9 polymerase in elongation state with continuous pol ii ps5 ctd peptide mimic bound in site 1a/2a |
|
54
|
249
|
8pnqC |
Influenza a/h7n9 polymerase in elongation state with continuous pol ii ps5 ctd peptide mimic bound in site 1a/2a |
|
225
|
757
|
8pnqB |
Influenza a/h7n9 polymerase in elongation state with continuous pol ii ps5 ctd peptide mimic bound in site 1a/2a |
|
111
|
403
|
8wwoA |
Crystal structure of the afsv topoisomerase atpase domain in complex with amppnp |
|
33
|
72
|
8x7xC |
Crystal structure of sads-cov fusion core |
|
159
|
670
|
8pohB |
Influenza a/h7n9 polymerase symmetric dimer bound to the promoter (pa k289a/c489r) |
|
229
|
1123
|
8cinA |
Ba.4/5-5 fab in complex with sars-cov-2 ba.4 spike glycoprotein |
|
98
|
296
|
8rzeA |
Sars-cov-2 nsp16-nsp10 in complex with sam derivative inhibitor 10 |
|
29
|
116
|
8rzcB |
Sars-cov-2 nsp16-nsp10 in complex with sam derivative inhibitor 11 |
|
21
|
131
|
8g5bJ |
Influenza a h3n2 x-31 hemagglutinin in complex with fl-1061 |
|
93
|
305
|
8cdcA |
Native 3clpro from sars-cov-2 at 1.54 a |
|
31
|
121
|
8g5bH |
Influenza a h3n2 x-31 hemagglutinin in complex with fl-1061 |
|
0
|
23
|
8pnpG |
Influenza a/h7n9 polymerase in pre-initiation state with continuous pol ii ps5 ctd peptide mimic bound in site 1a/2a |
|
46
|
214
|
8cinF |
Ba.4/5-5 fab in complex with sars-cov-2 ba.4 spike glycoprotein |
|
38
|
223
|
8cinE |
Ba.4/5-5 fab in complex with sars-cov-2 ba.4 spike glycoprotein |
|
71
|
270
|
8g5bA |
Influenza a h3n2 x-31 hemagglutinin in complex with fl-1061 |
|
17
|
112
|
8g5bL |
Influenza a h3n2 x-31 hemagglutinin in complex with fl-1061 |
|
44
|
213
|
8g5aL |
X-31 hemagglutinin in complex with fl-1061 fab |
|
153
|
493
|
8g5aA |
X-31 hemagglutinin in complex with fl-1061 fab |
|
38
|
221
|
8g5bI |
Influenza a h3n2 x-31 hemagglutinin in complex with fl-1061 |
|
38
|
221
|
8g5aH |
X-31 hemagglutinin in complex with fl-1061 fab |
|
21
|
103
|
8g5bN |
Influenza a h3n2 x-31 hemagglutinin in complex with fl-1061 |
|
51
|
213
|
8g5bM |
Influenza a h3n2 x-31 hemagglutinin in complex with fl-1061 |
|
125
|
537
|
8pm0C |
Influenza a/h7n9 polymerase in replicase-like conformation in pre-initiation state with pol ii ps5 ctd peptide mimic bound in site 1a/2a |
|
55
|
249
|
8pnpC |
Influenza a/h7n9 polymerase in pre-initiation state with continuous pol ii ps5 ctd peptide mimic bound in site 1a/2a |
|
24
|
207
|
8pohC |
Influenza a/h7n9 polymerase symmetric dimer bound to the promoter (pa k289a/c489r) |
|
194
|
1128
|
7xoeA |
Cryo-em structure of s glycoprotein encoded by the covid-19 mrna vaccine candidate rq3013 (prefusion state) |
|
100
|
297
|
8rv5A |
Sars-cov-2 nsp16-nsp10 in complex with sam derivative inhibitor 1 |
|
29
|
115
|
8rv6B |
Sars-cov-2 nsp16-nsp10 in complex with sam derivative inhibitor 2 |
|
27
|
115
|
8rv8B |
Sars-cov-2 nsp16-nsp10 in complex with sam derivative inhibitor 5 |
|
88
|
301
|
7grwA |
Crystal structure of sars-cov-2 main protease in complex with cpd-19 |
|
86
|
300
|
7grrA |
Crystal structure of sars-cov-2 main protease in complex with cpd-14 |
|
83
|
301
|
7grhA |
Crystal structure of sars-cov-2 main protease in complex with cpd-4 |
|
79
|
317
|
8tj9A |
Crystal structure of the a/michigan/15/2014(h3n2) influenza virus hemagglutinin with human receptor analog 6'-slnln |
|
86
|
306
|
7grgA |
Crystal structure of sars-cov-2 main protease in complex with cpd-3 |
|
61
|
173
|
8tj8B |
Crystal structure of the a/moscow/10/1999(h3n2) influenza virus hemagglutinin with human receptor analog 6'-slnln |
|
85
|
301
|
7grkA |
Crystal structure of sars-cov-2 main protease in complex with cpd-7 |
